Cargando…
Detection of Red Blood Cell Membrane Proteins in Myelodysplastic Syndromes Using Eosin-5-Maleimide (EMA) Staining by Flow Cytometry
Background: Eosin-5-Maleimide (EMA)-based flow cytometry binds to red blood cell (RBC) membrane-associated proteins which can be used to detect red blood cell (RBC) membrane disorders. Myelodysplastic syndromes (MDS) are stem cell disorders resulting in ineffective hematopoiesis which is commonly pr...
Autores principales: | Uman, Navavee, Kobbuaklee, Sirorat, Kansuwan, Patsita, Watanaboonyongcharoen, Phandee, Polprasert, Chantana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955372/ https://www.ncbi.nlm.nih.gov/pubmed/35323174 http://dx.doi.org/10.3390/hematolrep14010003 |
Ejemplares similares
-
Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes
por: Hattakitpanitchakul, Saroj, et al.
Publicado: (2021) -
Prognostic factors and impact of CMV reactivation on acute myeloid leukemia patients after HLA-matched myeloablative allogeneic stem cell transplantation in a high CMV prevalence country
por: Chanswangphuwana, Chantiya, et al.
Publicado: (2023) -
Mean corpuscular volume of control red blood cells determines the interpretation of eosin-5′-maleimide (EMA) test result in infants aged less than 6 months
por: Ciepiela, Olga, et al.
Publicado: (2015) -
Analysis of Hereditary Elliptocytosis with Decreased Binding of Eosin-5-maleimide to Red Blood Cells
por: Suemori, Shin-ichiro, et al.
Publicado: (2015) -
Stability of eosin-5'-maleimide dye used in flow cytometric analysis for red cell membrane disorders
por: Mehra, Simmi, et al.
Publicado: (2015)